{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T04:16:20Z","timestamp":1742012180804,"version":"3.38.0"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,3,15]]},"DOI":"10.2169\/internalmedicine.4133-24","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T22:12:44Z","timestamp":1723241564000},"page":"937-940","source":"Crossref","is-referenced-by-count":0,"title":["Dopa-responsive Rest Tremor Preceding Tachyphemia in Progressive Supranuclear Palsy"],"prefix":"10.2169","volume":"64","author":[{"given":"Takuro","family":"Shiga","sequence":"first","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Ishiyama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Sugeno","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Nozue","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Kakinuma","sequence":"additional","affiliation":[{"name":"Department of Behavioral and Cognitive Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Williams DR, Holton JL, Strand C, et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain 130 (Pt 6): 1566-1576, 2007.","DOI":"10.1093\/brain\/awm104"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hoglinger GU, Respondek G, Stamelou M, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32: 853-864, 2017.","DOI":"10.1002\/mds.26973"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Williams DR, Holton JL, Strand K, Revesz T, Lees AJ. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 22: 2235-2241, 2007.","DOI":"10.1002\/mds.21698"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Elkouzi A, Bit-Ivan EN, Elble RJ. Pure akinesia with gait freezing: a clinicopathologic study. J Clin Mov Disord 4: 15, 2017.","DOI":"10.1186\/s40734-017-0063-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zach H, Dirkx MF, Roth D, Pasman JW, Bloem BR, Helmich RC. Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease. Neurology 95: e1461-e1470, 2020.","DOI":"10.1212\/WNL.0000000000010316"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fujioka S, Algom AA, Murray ME, et al. Tremor in progressive supranuclear palsy. Parkinsonism Relat Disord 27: 93-97, 2016.","DOI":"10.1016\/j.parkreldis.2016.03.015"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 30: 1591-1601, 2015.","DOI":"10.1002\/mds.26424"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ. A clinico-pathological study of subtypes in Parkinson's disease. Brain 132 (Pt 11): 2947-2957, 2009.","DOI":"10.1093\/brain\/awp234"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Grimm MJ, Respondek G, Stamelou M, et al. How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy. Mov Disord 34: 1228-1232, 2019.","DOI":"10.1002\/mds.27666"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Baba T, Kikuchi A, Hirayama K, et al. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. Brain 135 (Pt 1): 161-169, 2012.","DOI":"10.1093\/brain\/awr321"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fearon C, Field R, Donlon E, et al. The "round the houses" sign and "zig-zag" sign in progressive supranuclear palsy and other conditions. Parkinsonism Relat Disord 81: 94-95, 2020.","DOI":"10.1016\/j.parkreldis.2020.10.030"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Orimo S, Suzuki M, Inaba A, Mizusawa H. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord 18: 494-500, 2012.","DOI":"10.1016\/j.parkreldis.2012.01.009"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Daoudi K, Das B, Tykalova T, Klempir J, Rusz J. Speech acoustic indices for differential diagnosis between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. NPJ Parkinsons Dis 8: 142, 2022.","DOI":"10.1038\/s41531-022-00389-6"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gallay MN, Moser D, Magara AE, Haufler F, Jeanmonod D. Bilateral MR-guided focused ultrasound pallidothalamic tractotomy for Parkinson's disease with 1-year follow-up. Front Neurol 12: 601153, 2021.","DOI":"10.3389\/fneur.2021.601153"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Penney JB Jr., Young AB. GABA as the pallidothalamic neurotransmitter: implications for basal ganglia function. Brain Res 207: 195-199, 1981.","DOI":"10.1016\/0006-8993(81)90693-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Saranza G, Lang AE. Levodopa challenge test: indications, protocol, and guide. J Neurol 268: 3135-3143, 2021.","DOI":"10.1007\/s00415-020-09810-7"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/6\/64_4133-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T03:31:23Z","timestamp":1742009483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/6\/64_4133-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4133-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"article-number":"4133-24"}}